The US Food and Drug Administration (FDA) plans to reduce or eliminate animal testing in medicine development, citing cost savings and potential benefits for consumers. To achieve this goal, the agency will encourage researchers to use advanced technologies like computer modeling, artificial intelligence, and organs-on-a-chip. These tools will help predict drug performance and effectiveness in real-world scenarios using existing safety data from other countries. The move aims to accelerate the development of cures and treatments while minimizing animal testing, as stated by FDA Commissioner Martin Makary.
Source: https://www.statnews.com/pharmalot/2025/04/11/fda-animals-dogs-primates-pharma-biotech-medicines-research-development